Abstract
Objectives: To determine the prevalence of inappropriate prescribing, defined by applying modified Beers’ criteria, and to examine the influence of the Pharmaceutical Benefits Scheme (PBS), Australia’s national scheme for subsidising medicines, on inappropriate prescribing.Methods: Cross-sectional survey of nursing home records, including 7-days data from medication charts.Setting: Fiveteen randomly selected nursing homes (998 residents) in Southeast Queensland and Northern New South Wales, Australia.Main outcome measures: The prevalence of inappropriate prescribing as defined by modified Beers’ criteria and its correlation with PBS restrictions.Results: 18.5% of residents were ordered one or more inappropriate medications, and 1.5% of residents were ordered two or more. The level of PBS restriction and the percentage of residents ordered a medication were highly correlated (ρ = -0.87, P<0.001). Medications in Beers’ criteria that were not listed (subsidised) on the PBS were not ordered for any resident. PBS medicines with subsidies restricted to certain populations or indications were ordered for 0% to 0.1% of residents. Dextropropoxyphene, diazepam, amitriptyline and methyldopa were the only medications in Beers’ criteria prescribed to more than 0.5% of residents. Dextropropoxyphene was only subsidised for war veterans, with a caution warning of its potential to cause drug dependence, while diazepam, amitriptyline and methyldopa were listed on the PBS without any subsidy restrictions.Conclusion: Increases in the level of PBS restriction were associated with decreases in the prevalence of inappropriate prescribing, The targeting of drug subsidies to reduce inappropriate prescribing warrants further investigation.
Similar content being viewed by others
References
Department of Health Housing Local Government and Community Services. Schedule of pharmaceutical benefits for approved pharmacists and medical practitioners. 1 Dec 1993 ed. Canberra: Australian Government Publishing Service, 1993
Commonwealth Department of Health and Ageing. General Public: Pharmaceutical Benefits Scheme. Canberra: Commonwealth Department of Health and Ageing, 2003 Available at http://www.health.gov.au/pbs/general/listing/committee.htm (accessed May 2004)
Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 1991; 151(9):1825–1832
Aparasu RR, Mort JR. Inappropriate prescribing for the elderly: Beers criteria-based review. Ann Pharmacother 2000; 34(3):338–346
Dhalla IA, Anderson GM, Mamdani MM, Bronskill SE, Sykora K, Rochon PA. Inappropriate prescribing before and after nursing home admission. J Am Geriatr Soc 2002; 50(6):995–1000
Onder G, Landi F, Cesari M, Gambassi G, Carbonin P, Bernabei R. Inappropriate medication use among hospitalized older adults in Italy: results from the Italian Group of Pharmacoepidemiology in the Elderly. Eur J Clin Pharmacol 2003; 59(2):157–162
Chin MH, Wang LC, Jin L, Mulliken R, Walter J, Hayley DC et al. Appropriateness of medication selection for older persons in an urban academic emergency department. Acad Emerg Med 1999; 6(12):1232–4242
Lau GT. Hospitalization and death associated with potentially inappropriate medication prescriptions among geriatric nursing home residents. Academy Health Annual Research Meeting 2002 Abstract available at http://www. academyhealth.org/arm/ (accessed Mar 2004)
Fick DM, Waller JL, Maclean JR, Vanden Heuvel R, Tadlock JG, Gottlieb M et al. Potentially inappropriate medication use in a Medicare managed care population: association with higher costs and utilization. J Manag Care Pharm 2001; 7(5):407–413
Roberts MS, King M, Stokes JA, Lynne TA, Bonner CJ, McCarthy S et al. Medication prescribing and administration in nursing homes. Age Ageing 1998; 27(3):385–392
Roberts MS, Stokes JA, King MA, Lynne TA, Purdie DM, Glasziou PP et al. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol 2001; 51(3):257–265
Beers MH, Ouslander JG, Fingold SF, Morgenstern H, Reuben DB, Rogers W et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med 1992; 117(8):684–689
Liaw ST, Pearce CM, Chondros P, McGrath BP, Piggford L, Jones K. Doctors’ perceptions and attitudes to prescribing within the Authority Prescribing System. Med J Aust 2003; 178(5):203–606
Goulding MR. Inappropriate medication prescribing for elderly ambulatory care patients. Arch Intern Med 2004; 164(3):305–312
King MA, Purdie DM, Roberts MS. Matching prescription claims with medication data for nursing home residents: implications for prescriber feedback, drug utilisation studies and selection of prescription claims database. J Clin Epidemiol 2001; 54(2):202–909
Schneeweiss S, Maclure M, Carleton B, Glynn RJ, Avorn J. Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: direct comparison of randomised and observational evaluations. BMJ 2004; 328(7439):560
Lindley CM, Tully MP, Paramsothy V, Tallis RC. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992; 21(4):294–300
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
King, M.A., Roberts, M.S. The influence of the Pharmaceutical Benefits Scheme (PBS) on inappropriate prescribing in Australian nursing homes. Pharm World Sci 29, 39–42 (2007). https://doi.org/10.1007/s11096-005-5618-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-005-5618-9